Methylene blue is associated with poor outcomes in vasoplegic shock

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 27, Issue 6, 2013, Pages 1233-1238

  Weiner, Menachem M ^a   Lin, Hung Mo ^a   Danforth, Dennis ^a   Rao, Srikar ^b   Hosseinian, Leila ^a   Fischer, Gregory W ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cardiac surgery; methylene blue; outcome; vasoplegia; vasoplegic shock

Indexed keywords

METHYLENE BLUE;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART OUTPUT; HEART SURGERY; HUMAN; HYPERBILIRUBINEMIA; KIDNEY FAILURE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OUTCOME ASSESSMENT; PEROPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL MORTALITY; VASOPLEGIA; VENTRICULAR ASSIST DEVICE;

CARDIAC SURGERY; METHYLENE BLUE; OUTCOME; VASOPLEGIA; VASOPLEGIC SHOCK;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIDOTES; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; FEMALE; HOSPITAL MORTALITY; HUMANS; LOGISTIC MODELS; MALE; METHYLENE BLUE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROPENSITY SCORE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VASOPLEGIA; YOUNG ADULT;

EID: 84888300382     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2013.02.026     Document Type: Article

References (24)

1. G. Shanmugam Vasoplegic syndrome - The role of methylene blue Eur J Cardiothorac Surg 28 2005 705 710
2. G.W. Fischer, and M.A. Levin Vasoplegia during cardiac surgery: Current concepts and management Semin Thorac Cardiovasc Surg 22 2010 140 144
3. R.L. Levin, M.A. Degrange, and G.F. Bruno Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery Ann Thorac Surg 77 2004 496 499
4. R.G. Leyh, T. Kofidis, and M. Strüber Methylene blue: The drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass? J Thorac Cardiovasc Surg 125 2003 1426 1431
5. M.A. Levin, H.M. Lin, and J.G. Castillo Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome Circulation 120 2009 1664 1671
6. S.A.M. Nashef, F. Roques, and P. Michel European system for cardiac operative risk evaluation (EuroSCORE) Eur J Cardiothorac Surg 16 1999 9 13
7. American Thoracic Society Infectious Diseases Society of America: Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia Am J Respir Crit Care Med 171 2005 388 416
8. A. Lever, and I. Mackenzie Sepsis: Definition, epidemiology, and diagnosis BMJ 335 2007 879 883
9. A.D. Maslow, G. Stearns, and P. Butala The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass Anesth Analg 103 2006 2 8
10. M. Argenziano, J.M. Chen, and A.F. Choudhri Management of vasodilatory shock after cardiac surgery: Identification of predisposing factors and use of a novel pressor agent J Thorac Cardiovasc Surg 116 1998 973 980
11. W.J. Gomes, M.R. Erlichman, and M.L. Batista-Filho Vasoplegic syndrome after off-pump coronary artery bypass surgery Eur J Cardiothorac Surg 23 2003 165 169
12. I.H. Koh, J.L. Menchaca-Diaz, and T.H. Koh Microcirculatory evaluation in sepsis: A difficult task Shock 34 Suppl 1 2010 27 33
13. S. Pagni, and E.H. Austin Use of intravenous methylene blue for treatment of refractory hypotension after cardiopulmonary bypass J Thorac Cardiovasc Surg 119 2000 1297 1298
14. G.W. Fischer, Y. Bengtsson, and S. Scarola Methylene blue for vasopressor-resistant vasoplegia syndrome during liver transplantation J Cardiothorac Vasc Anesth 24 2010 463 466
15. H. Riha, and J.G. Augoustides Pro: Methylene blue as a rescue therapy for vasoplegia after cardiac surgery J Cardiothorac Vasc Anesth 25 2011 736 738
16. J.S. Cho, J.W. Song, and S. Na Effect of a single bolus of methylene blue prophylaxis on vasopressor and transfusion requirement in infective endocarditis patients undergoing cardiac surgery Korean J Anesthesiol 63 2012 142 148
17. M.J. Andritsos Con: Methylene blue should not be used routinely for vasoplegia perioperatively J Cardiothorac Vasc Anesth 25 2011 739 743
18. P.R. Evora, P.J. Ribeiro, and W.V. Vicente Methylene blue for vasoplegic syndrome treatment in heart surgery: Fifteen years of questions, answers, doubts and certainties Rev Bras Cir Cardiovasc 24 2009 279 288
19. E. Ozal, E. Kuralay, and V. Yildirim Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery Ann Thorac Surg 79 2005 1615 1619
20. S. Lenglet, F. Mach, and F. Montecucco Methylene blue: Potential use of an antique molecule in vasoplegic syndrome during cardiac surgery Expert Rev Cardiovasc Ther 9 2011 1519 1525
21. M.R. Sills, and W.H. Zinkham Methylene blue-induced Heinz body hemolytic anemia Arch Pediatr Adolesc Med 148 1994 306 310
22. B.G. Harbrech, B. Wu, and S.C. Watkins Inhibition of nitric oxide synthase during hemorrhagic shock increases hepatic injury Shock 4 1995 332 337
23. H. Zhang, P. Rogiers, and J.C. Preiser Effects of methylene blue on oxygen availability and regional blood flow during endotoxic shock Crit Care Med 123 1995 1711 1721
24. N.P. Juffermans, M.G. Vervloet, and C.R. Daemen-Gubbels A dose-finding study of methylene blue to inhibit nitric oxide actions in the hemodynamics of human septic shock Nitric Oxide 22 2010 275 280